BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 9309783)

  • 21. [Immunohistochemical studies on epidermal growth factor receptor and the myc oncogene product in squamous cell carcinoma of the uterine cervix].
    Yamasaki M; Maruo T; Akahori T; Mochizuki M
    Nihon Sanka Fujinka Gakkai Zasshi; 1988 Jan; 40(1):51-8. PubMed ID: 3280708
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Peritumoral lymphatic vessel density and vascular endothelial growth factor C expression in early-stage squamous cell carcinoma of the uterine cervix.
    Gombos Z; Xu X; Chu CS; Zhang PJ; Acs G
    Clin Cancer Res; 2005 Dec; 11(23):8364-71. PubMed ID: 16322297
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Epidermal growth factor receptor, MUC-1 and MUC-2 in bladder cancer.
    Cardillo MR; Castagna G; Memeo L; De Bernardinis E; Di Silverio F
    J Exp Clin Cancer Res; 2000 Jun; 19(2):225-33. PubMed ID: 10965823
    [TBL] [Abstract][Full Text] [Related]  

  • 24. CD105 microvessels density, VEGF, EGFR-1 and c-erbB-2 and their prognostic correlation in different subtypes of cervical adenocarcinoma.
    Barbu I; Crăiţoiu S; Simionescu CE; Drâgnei AM; Mărgăritescu C
    Rom J Morphol Embryol; 2013; 54(3):519-30. PubMed ID: 24068399
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Tannic acid binding of cell surfaces in normal, premalignant, and malignant squamous epithelium of the human uterine cervix.
    Davina JH; Lamers GE; van Haelst UJ; Kenemans P; Stadhouders AM
    Ultrastruct Pathol; 1984; 6(4):275-84. PubMed ID: 6485120
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Oncogenes and tumor angiogenesis: the HPV-16 E6 oncoprotein activates the vascular endothelial growth factor (VEGF) gene promoter in a p53 independent manner.
    López-Ocejo O; Viloria-Petit A; Bequet-Romero M; Mukhopadhyay D; Rak J; Kerbel RS
    Oncogene; 2000 Sep; 19(40):4611-20. PubMed ID: 11030150
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Epidermal growth factor receptor coexpression modulates susceptibility to Herceptin in HER2/neu overexpressing breast cancer cells via specific erbB-receptor interaction and activation.
    Diermeier S; Horváth G; Knuechel-Clarke R; Hofstaedter F; Szöllosi J; Brockhoff G
    Exp Cell Res; 2005 Apr; 304(2):604-19. PubMed ID: 15748904
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cyclooxygenase-2 and c-erbB-2 expression in uterine cervical neoplasm assessed using tissue microarrays.
    Kim JY; Lim SJ; Park K; Lee CM; Kim J
    Gynecol Oncol; 2005 May; 97(2):337-41. PubMed ID: 15863127
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Expression and clinical significance of HMGB1 and RAGE in cervical squamous cell carcinoma].
    Hao Q; Du XQ; Fu X; Tian J
    Zhonghua Zhong Liu Za Zhi; 2008 Apr; 30(4):292-5. PubMed ID: 18788635
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Phosphorylation of EGFR measured with in situ proximity ligation assay: relationship to EGFR protein level and gene dosage in cervical cancer.
    Halle C; Lando M; Sundfør K; Kristensen GB; Holm R; Lyng H
    Radiother Oncol; 2011 Oct; 101(1):152-7. PubMed ID: 21680035
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prognostic significance of tumor angiogenesis, Ki 67, p53 oncoprotein, epidermal growth factor receptor and HER2 receptor protein expression in undifferentiated nasopharyngeal carcinoma--a prospective study.
    Ma BB; Poon TC; To KF; Zee B; Mo FK; Chan CM; Ho S; Teo PM; Johnson PJ; Chan AT
    Head Neck; 2003 Oct; 25(10):864-72. PubMed ID: 12966511
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hypoxia-inducible erythropoietin signaling in squamous dysplasia and squamous cell carcinoma of the uterine cervix and its potential role in cervical carcinogenesis and tumor progression.
    Acs G; Zhang PJ; McGrath CM; Acs P; McBroom J; Mohyeldin A; Liu S; Lu H; Verma A
    Am J Pathol; 2003 Jun; 162(6):1789-806. PubMed ID: 12759237
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Differentiation and proliferation patterns in human trophoblast revealed by c-erbB-2 oncogene product and EGF-R.
    Mühlhauser J; Crescimanno C; Kaufmann P; Höfler H; Zaccheo D; Castellucci M
    J Histochem Cytochem; 1993 Feb; 41(2):165-73. PubMed ID: 8093455
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Immunoreactivity of involucrin in cervical condyloma and intraepithelial neoplasia.
    Saito K; Saito A; Fu YS; Cheng L; Hilborne LH
    Int J Gynecol Pathol; 1986; 5(4):308-18. PubMed ID: 3542863
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Epithelial-mesenchymal transition in cervical cancer: correlation with tumor progression, epidermal growth factor receptor overexpression, and snail up-regulation.
    Lee MY; Chou CY; Tang MJ; Shen MR
    Clin Cancer Res; 2008 Aug; 14(15):4743-50. PubMed ID: 18676743
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Expression of c-erbB-2 oncogene protein, epidermal growth factor receptor, and TGF-beta1 in human pancreatic ductal adenocarcinoma.
    Zhang L; Yuan SZ
    Hepatobiliary Pancreat Dis Int; 2002 Nov; 1(4):620-3. PubMed ID: 14607699
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Vascular endothelial growth factor (VEGF) up-regulates epidermal growth factor receptor (EGF-R) in cervical cancer in vitro: this action is mediated through HPV-E6 in HPV-positive cancers.
    Mathur RS; Mathur SP
    Gynecol Oncol; 2005 Apr; 97(1):206-13. PubMed ID: 15790460
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clinicopathologic and molecular markers in cervical carcinoma: a prospective cohort study.
    Halle MK; Ojesina AI; Engerud H; Woie K; Tangen IL; Holst F; Høivik E; Kusonmano K; Haldorsen IS; Vintermyr OK; Trovik J; Bertelsen BI; Salvesen HB; Krakstad C
    Am J Obstet Gynecol; 2017 Oct; 217(4):432.e1-432.e17. PubMed ID: 28599900
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [EGF receptor and effects of EGF on growth and tumor marker secretion in uterine cervical cancer cells].
    Ueda M; Okamoto Y; Yamada T; Misaki O; Tsurunaga T; Iwai E; Yanagawa Y; Ueki M; Sugimoto O
    Nihon Sanka Fujinka Gakkai Zasshi; 1988 Nov; 40(11):1700-6. PubMed ID: 3266224
    [TBL] [Abstract][Full Text] [Related]  

  • 40. In situ adenocarcinoma and squamous carcinoma of uterine cervix. Pathological and immunohistochemical analysis with cytokeratin 13.
    Raspollini MR; Fambrini M; Marchionni M; Baroni G; Taddei GL
    Eur J Obstet Gynecol Reprod Biol; 2007 Oct; 134(2):249-53. PubMed ID: 16949723
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.